{
    "id": "3171cd9e-bcd2-45a9-b825-b0e146a222bd",
    "indications": {
        "text": "anagrelide capsules indicated treatment patients thrombocythemia , secondary myeloproliferative neoplasms , reduce elevated platelet count risk thrombosis ameliorate associated symptoms including thrombo-hemorrhagic events .",
        "doid_entities": [
            {
                "text": "thrombosis (DOID:0060903)",
                "doid_id": "http://purl.obolibrary.org/obo/DOID_0060903"
            }
        ],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "starting dose adults 0.5 mg four times day 1 mg twice day . ( 2.1 ) starting dose pediatric patients 0.5 mg per day . ( 2.1 ) maintain starting dose least one week titrate maintain target platelet counts . ( 2.2 ) exceed dose increment 0.5 mg/day one week . exceed 10 mg/day 2.5 mg single dose . ( 2.2 ) moderate hepatic impairment : start 0.5 mg per day . ( 2.3 )",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "anagrelide capsules usp , 0.5 mg available light gray opaque cap/white opaque body hard gelatin capsules , spin printed black ink \u201c ivax hourglass logo \u201d \u201c 5241 \u201d cap \u201c 0.5 mg \u201d body containing 0.5 mg anagrelide base ( anagrelide hydrochloride , usp ) . ndc 0172-5241-60 0.5 mg packaged bottles 100 capsules anagrelide capsules usp , 1 mg available white opaque hard gelatin capsules , spin printed black ink \u201c ivax hourglass logo \u201d \u201c 5240 \u201d cap \u201c 1 mg \u201d body containing 1 mg anagrelide base ( anagrelide hydrochloride , usp ) . ndc 0172-5240-60 1 mg packaged bottles 100 capsules store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . dispense tight , light-resistant container defined usp , child-resistant closure ( required ) . keep medications reach children .",
    "adverseReactions": "none .",
    "ingredients": [
        {
            "name": "ANAGRELIDE HYDROCHLORIDE",
            "code": "YTM763Y5C8",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_55345"
        },
        {
            "name": "FERROSOFERRIC OXIDE",
            "code": "XM0M87F357",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_50821"
        },
        {
            "name": "CROSPOVIDONE (15 MPA.S AT 5%)",
            "code": "68401960MK"
        },
        {
            "name": "D&C YELLOW NO. 10 ALUMINUM LAKE",
            "code": "CQ3XH3DET6"
        },
        {
            "name": "FD&C BLUE NO. 1 ALUMINUM LAKE",
            "code": "J9EQA3S2JM"
        },
        {
            "name": "FD&C BLUE NO. 2--ALUMINUM LAKE",
            "code": "4AQJ3LG584"
        },
        {
            "name": "FD&C RED NO. 40",
            "code": "WZB9127XOA"
        },
        {
            "name": "GELATIN",
            "code": "2G86QN327L",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_5291"
        },
        {
            "name": "ANHYDROUS LACTOSE",
            "code": "3SY5LH9PMK",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "POVIDONE K30",
            "code": "U725QWY32X",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14478"
        },
        {
            "name": "PROPYLENE GLYCOL",
            "code": "6DC9Q167V3",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_13643"
        },
        {
            "name": "SHELLAC",
            "code": "46N107B71O"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_32234"
        }
    ],
    "organization": "Teva Pharmaceuticals USA, Inc.",
    "name": "Anagrelide Hydrochloride",
    "effectiveTime": "20220302",
    "indications_original": "Anagrelide capsules are indicated for the treatment of patients with thrombocythemia, secondary to myeloproliferative neoplasms, to reduce the elevated platelet count and the risk of thrombosis and to ameliorate associated symptoms including thrombo-hemorrhagic events.",
    "contraindications_original": "The starting dose for adults is 0.5 mg four times a day or 1 mg twice a day. ( 2.1 ) The starting dose for pediatric patients is 0.5 mg per day. ( 2.1 ) Maintain the starting dose for at least one week and then titrate to maintain target platelet counts. ( 2.2 ) Do not exceed a dose increment of 0.5 mg/day in any one week. Do not exceed 10 mg/day or 2.5 mg in a single dose. ( 2.2 ) Moderate hepatic impairment: Start with 0.5 mg per day. ( 2.3 )",
    "warningsAndPrecautions_original": "Anagrelide Capsules USP, 0.5 mg are available as light gray opaque cap/white opaque body hard gelatin capsules, spin printed in black ink \u201cIvax hourglass logo\u201d \u201c5241\u201d on the cap and \u201c0.5 mg\u201d on the body containing 0.5 mg of anagrelide base (as anagrelide hydrochloride, USP). \n                  NDC 0172-5241-60\t0.5 mg packaged in bottles of 100 capsules\n                  Anagrelide Capsules USP, 1 mg are available as white opaque hard gelatin capsules, spin printed in black ink \u201cIvax hourglass logo\u201d \u201c5240\u201d on the cap and \u201c1 mg\u201d on the body containing 1 mg of anagrelide base (as anagrelide hydrochloride, USP). \n                  NDC 0172-5240-60\t1 mg packaged in bottles of 100 capsules\n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [See USP Controlled Room Temperature].\n                  Dispense in a tight, light-resistant container as defined in the USP, with a child-resistant closure (as required).\n                  KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.",
    "adverseReactions_original": "None.",
    "drug": [
        {
            "name": "Anagrelide Hydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_55345"
        }
    ]
}